Statistics

Total Visits

Views
Bendamustine in combination with rituximab as first-line treatment for indolent non-hodgkin lymphoma: Retrospective analysis of An Spanish registry87

Select a period of time:

Number of views in the range

Views
Bendamustine in combination with rituximab as first-line treatment for indolent non-hodgkin lymphoma: Retrospective analysis of An Spanish registry20

Views

Views
October 20252
November 20253
December 20251
January 202611
February 20260
March 20263
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States14
United Kingdom3
Argentina1
Egypt1
Finland1
 

Top cities views

Views
San Jose11
Helsinki1